Thursday, February 10, 2011

Pulmonology

Pulmonology Pulmonology denormalization is a strategy to change social norms and reinforcing the public perception of smoking as hazardous to health, socially unacceptable behavior. Karen Calabro, DrPH, Ramara Costello and Alexander Prokhorov, MD, PhD, MD Anderson Cancer Center (Houston, Texas) described in many ways, pediatricians and other health professionals can help their patients and communities for use as snuff undesirable: through direct communication with patients and their families by providing information and referrals for prevention and cessation programs of snuff, giving the example of a lifestyle without snuff, and advocate for stronger public policies to reduce consumption of snuff and exposure. In the article entitled “The consumption of snuff denormalization and the role of pediatric health care provider, the authors argue that health professionals can have a significant and positive impact on the health of children, working to de-normalize snuff consumption.

“For years, tobacco has been the promotion of its toxic properties of what people are popular, successful, glamorous, sexy, confident and athletic, and is not independent. It is time to start re-claim the truth. The use of a product that hurts you and everyone around you is not something to be glorified. The implementation of strategies aimed at changing public perceptions about the snuff have had a substantial reduction in smoking among young people – and have been vigorously fought by the tobacco industry pediatricians, as advocates of children’s health, they have to send strong messages to their patients and communities. to fight against the deceptions of the snuff industry, “said Harold Farber, MD, MSPH, editor Chief of Pediatric Allergy, Immunology and Respiratory Medicine, and Associate Professor of Pediatrics, Division of Pulmonary, Baylor College of Medicine, Houston, TX.

Pediatric allergy, immunology, pulmonology, and is published quarterly in print and online. The Journal has expanded its coverage to the synthesis of pulmonary allergy and immunology at the promotion of children’s respiratory health. The Journal provides comprehensive coverage to promote understanding and optimize the treatment of certain chronic childhood illness most common and costly. It includes original research, translation, clinical epidemiology, public health, quality improvement, and case-control studies, research on patient education, and the latest genetic research and standards of care and functional immunodeficiencies and interstitial lung disease. Table of Contents and a free copy can be accessed online.
Comments
0 Comments

0 comments:

Post a Comment